This is the structural argument, and it is an argument, not a quoted fact, so take it as the inference it is: a molecule this large and this complex, with no legitimate manufacturer and no reference standard, produced by the cheapest possible synthesis for an unregulated market, is close to impossible to make cleanly and impossible for the buyer to verify
You may be eligible to participate if you are 18 or older and have: Been diagnosed with painful diabetic peripheral neuropathy or report pain that is consistent with a diagnosis and has been going on for at least three months Been diagnosed with type 2 diabetes at least six months prior to screening Been taking any diabetes or pain medications that you are using regularly for at least three months prior to screening An A1C of 6.0-10.5% at screening A BMI greater than 25 Women who are pregnant, breastfeeding, or planning to become pregnant are not eligible to participate
The most common side effects include constipation, diarrhea, nausea, reduced appetite and vomiting
Its main side effects match those seen with Retatrutide: nausea, vomiting, and diarrhea are most common
Effective: Recent research found that oral semaglutide is equally, if not more, effective when compared to its injectable counterpart in managing type 2 diabetes (T2) while maintaining similar tolerability 2